Miracle’ cystic fibrosis drug kept out of reach in developing countries

7 February 2023 - Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients ...

Read more →

Impacts to medicine supply from India

12 May 2021 - PHARMAC is in constant contact with our suppliers as the impact of COVID-19 on India unfolds. ...

Read more →

Mylan prices its generic remdesivir in India at $64 per 100 mg vial

6 July 2020 - Mylan will launch a generic version of Gilead Sciences’ COVID-19 anti-viral remdesivir in India at 4,800 rupees, ...

Read more →

The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China

17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...

Read more →

The pandemic is a chance to revamp India’s pharmaceutical industry

9 May 2020 - Companies could switch from primarily making generics to producing higher-margin licensed drugs. ...

Read more →

Maker of drug touted as coronavirus cure accuses China of gouging

24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy. ...

Read more →

India again allows export of anti-malarial drug touted for coronavirus

7 April 2020 - President Trump had urged the country, one of hydroxychloroquine’s biggest producers, to release supplies of the medicine. ...

Read more →

India has cut off half the supply of a potential coronavirus treatment touted by Trump

6 April 2020 - Nearly half the supply of hydroxychloroquine to the U.S. comes from makers in India, a flow ...

Read more →

Trump administration in talks with India to avoid U.S. drug supply shortage

31 March 2020 - India, the top source of generic drugs and ingredients, has restricted exports but the U.S. wants exemptions ...

Read more →

India bans export of drug being tested for coronavirus treatment

25 March 2020 - India said on Wednesday it had banned the export of hydroxychloroquine and formulations of the malaria drug ...

Read more →

In generic drug plants in China and India, data falsification is still a problem

29 October 2019 - As the generic drug industry faces allegations of data manipulation, headlines about carcinogen-tainted blood pressure medicine, ...

Read more →

Terminally ill dad saves more than $200k bringing in cancer drugs from India

17 April 2018 - A Kiwi dad who's dying of lung cancer has been bypassing the PHARMAC system to get ...

Read more →

FDA collaborates to promote safety, quality in clinical trials done in India

12 July 2017 - After more than 16 hours of travel, we touch down in Mumbai late in the evening ...

Read more →